U.S. Markets close in 3 hrs 24 mins

Insmed (INSM) Looks Good: Stock Adds 5.9% in Session

Zacks Equity Research

Insmed Incorporated (INSM) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company, as the stock is now down nearly 8% since Feb 27, 2014.

The company has seen no estimate revision in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Insmed currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Other medical stocks worth considering include Alexion Pharmaceuticals, Inc. (ALXN), Alkermes plc (ALKS) and ANI Pharmaceuticals, Inc. (ANIP). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

INSMED INC (INSM): Free Stock Analysis Report


ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report

ALKERMES PLC ORD (ALKS): Free Stock Analysis Report

Zacks Investment Research